(innoven Partenaires S.a.) Ipsa, 10% Owner at EYEGATE PHARMACEUTICALS INC (EYEG), bought 1,029,859 shares at $6.00 ($2.8M) on 2015-02-19, disclosed to the SEC on 2015-02-23.
Open-market purchase of $2.8M EYEG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 524,998 | $0 | 0.0% |
| 2 | $4.20 | 138,194 | $580K | 20.9% |
| 3 | $6.00 | 366,667 | $2.2M | 79.1% |
| Total | $2.70 avg | 1,029,859 | $2.8M | 100% |